CIK 0001368514
- Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562590442
- Phone
- +1 201-478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4 Open-market buy Director bought 5,000 shares at $2.22 ($11,100)
- 4 Open-market buy EVP, CSO and CMO bought 4,000 shares at $2.20 ($8,800)
- 4 Open-market buy President and CEO bought 4,000 shares at $2.24 ($8,960)
- 4 Open-market buy Director bought 5,300 shares at an average $2.56 ($13,586)
- 4 Open-market buy Director bought 2,000 shares at $2.88 ($5,760)
- 4 Open-market buy Director bought 10,200 shares at an average $2.89 ($29,499)
- 4 Open-market buy President and CEO bought 6,000 shares at an average $3.04 ($18,260)
- 4 Open-market buy EVP, CFO bought 4,000 shares at $2.97 ($11,860)
- 4 Open-market buy EVP, CSO and CMO bought 7,000 shares at an average $2.88 ($20,150)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4/A Grant or award Director acquired 7,500 shares (grant or award)
- 4/A Grant or award Director acquired 7,500 shares (grant or award)
- 4/A Grant or award Director acquired 7,500 shares (grant or award)
- 4/A Grant or award Director acquired 7,500 shares (grant or award)
- 4/A Grant or award Director acquired 7,500 shares (grant or award)
- 4 Open-market buy 10% owner bought 500,000 shares at $2.10 ($1,050,000)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
Page 9 of 19 · 362 filings